Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole IM Depot

400 mg intramuscular injection of aripiprazole

Trial Locations (12)

20016

Comprehensive Clinical Development, Washington D.C.

32806

Compass Research, LLC, Orlando

34741

Accurate Clinical Trials, Kissimmee

63118

St. Louis Clinical Trials, St Louis

75243

Pillar Clinical Research, Dallas

78754

Community Clinical Research, Austin

90650

South Coast Clinical Trials, Norwalk

90703

Comprehensive Clinical Development, Cerritos

92102

CNRI-San Diego, San Diego

92701

Neuropsychiatric Research Center of Orange County, Santa Ana

92804

South Coast Clinical Trials, Anaheim

92845

Collaborative Neuroscience Network, Garden Grove

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT01552772 - Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole | Biotech Hunter | Biotech Hunter